Valsartan and atenolol in patients with severe essential hypertension
R Cifkova, J Peleška, J Hradec, H Rosolova… - Journal of human …, 1998 - nature.com
The aim of this study was to evaluate the efficacy and tolerability of valsartan, a new
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …
[引用][C] Valsartan and atenolol in patients with severe essentiale hypertension
R Cífková, J Peleška, J Hradec, H Rosolová… - 1998 - med.muni.cz
Valsartan and atenolol in patients with severe essentiale hypertension | Lékařská fakulta
Masarykovy univerzity | MED MUNI Přejít k obsahu | Přejít k hlavnímu menu | Přejít k …
Masarykovy univerzity | MED MUNI Přejít k obsahu | Přejít k hlavnímu menu | Přejít k …
Valsartan and atenolol in patients with severe essential hypertension.
R Cifkova, J Peleska, J Hradec, H Rosolová… - Journal of Human …, 1998 - europepmc.org
The aim of this study was to evaluate the efficacy and tolerability of valsartan, a new
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …
Valsartan and atenolol in patients with severe essential hypertension.
R Cifkova, J Peleška, J Hradec… - Journal of Human …, 1998 - search.ebscohost.com
The aim of this study was to evaluate the efficacy and tolerability of valsartan, a new
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …
Valsartan and atenolol in patients with severe essential hypertension
R Cifkova, J Peleska, J Hradec… - Journal of human …, 1998 - pubmed.ncbi.nlm.nih.gov
The aim of this study was to evaluate the efficacy and tolerability of valsartan, a new
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …
[PDF][PDF] Valsartan and atenolol in patients with severe essential hypertension
R Cifkova, J Peleška, J Hradec… - Journal of Human …, 1998 - researchgate.net
The aim of this study was to evaluate the efficacy and tolerability of valsartan, a new
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …
[引用][C] Valsartan and atenolol in patients with severe essential hypertension
R CIFKOVA, J PELESKA, J HRADEC… - Journal of human …, 1998 - pascal-francis.inist.fr
Valsartan and atenolol in patients with severe essential hypertension CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
Valsartan and atenolol in patients with severe essential hypertension.
R Cifkova, J Peleška, J Hradec… - Journal of Human …, 1998 - search.ebscohost.com
The aim of this study was to evaluate the efficacy and tolerability of valsartan, a new
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …
angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary …
[引用][C] Valsartan and atenolol in patients with severe essentiale hypertension
R Cífková, J Peleška, J Hradec, H Rosolová… - 1998 - med.muni.cz
Valsartan and atenolol in patients with severe essentiale hypertension | Faculty of Medicine
Masaryk University | MED MUNI Go to main content | Go to main menu | Go to search …
Masaryk University | MED MUNI Go to main content | Go to main menu | Go to search …